Normal somatic cells undergo only a limited number of divisions. This property is termed the finite replicative lifespan of cells, and the process that leads to the loss of proliferative potential is termed cellular or replicative senescence. Several lines of evidence suggest that senescent cells accumulate with age in vivo, and that a finite replicative lifespan may be a tumor suppressive mechanism. Replicative senescence is genetically controlled by multiple, dominant-acting loci. It is particularly stringent in human cells, which rarely if ever spontaneously acquire an infinite replicative lifespan. Two important phenotypic changes occur in senescent cells. One occurs in all cells: a stable reversible arrest of growth. The other is cell type- specific: a selective alteration in differentiated functions. In both cases, there are specific modifications in gene expression, but little is known about the prime cause(s) for these changes. This proposal aims to study transcriptional regulators whose expression or activity is altered when human fibroblasts undergo replicative senescence. Three types of molecules will be cloned and/or characterized: 1) basic helix-loop-helix (bHLH) transcription factors that appear to be important in the growth arrest and require a functional retinoblastoma tumor suppressor protein for activity; 2) a novel DNA binding activity expressed by senescent cells that appears to act as a transcriptional repressor; 3) an altered form of the E2F transcription factor that is a dominant negative regulator of E2F activity. The regulation and function of these genes will be studied in cultured human cells. Their biochemical activity (DNA binding, cofactor requirements, transactivation potential) will be determined by in vitro and transfection assays. Biological activity (effects on growth, lifespan, differentiated functions) will be assessed by transfection and microinjection experiments. These studies will provide mechanistic data on how the senescent phenotype is controlled, and insights into the role of cell senescence in tumor suppression and aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AG009909-09
Application #
2769309
Study Section
Special Emphasis Panel (ZRG2-HED-2 (01))
Program Officer
Sierra, Felipe
Project Start
1990-09-01
Project End
2000-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Biology
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Wiley, Christopher D; Schaum, Nicholas; Alimirah, Fatouma et al. (2018) Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype. Sci Rep 8:2410
Jeon, Ok Hee; David, Nathaniel; Campisi, Judith et al. (2018) Senescent cells and osteoarthritis: a painful connection. J Clin Invest 128:1229-1237
Wiley, Christopher D; Flynn, James M; Morrissey, Christapher et al. (2017) Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence. Aging Cell 16:1043-1050
Baar, Marjolein P; Brandt, Renata M C; Putavet, Diana A et al. (2017) Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell 169:132-147.e16
Demaria, Marco; O'Leary, Monique N; Chang, Jianhui et al. (2017) Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. Cancer Discov 7:165-176
Perrott, Kevin M; Wiley, Christopher D; Desprez, Pierre-Yves et al. (2017) Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience 39:161-173
Jeon, Ok Hee; Kim, Chaekyu; Laberge, Remi-Martin et al. (2017) Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med 23:775-781
Wiley, Christopher D; Campisi, Judith (2016) From Ancient Pathways to Aging Cells-Connecting Metabolism and Cellular Senescence. Cell Metab 23:1013-1021
Kruiswijk, F; Hasenfuss, S C; Sivapatham, R et al. (2016) Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling. Oncogene 35:2166-77
Campisi, Judith (2016) Cellular Senescence and Lung Function during Aging. Yin and Yang. Ann Am Thorac Soc 13 Suppl 5:S402-S406

Showing the most recent 10 out of 84 publications